{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:23:11Z","timestamp":1788618191483,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.mce.2022.111729","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T02:27:47Z","timestamp":1659234467000},"page":"111729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Improved lipogenesis gene expression in liver is associated with elevated plasma angiotensin 1-7 after AT1 receptor blockade in insulin-resistant OLETF rats"],"prefix":"10.1016","volume":"555","author":[{"given":"Jose A.","family":"Godoy-Lugo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9209-8225","authenticated-orcid":false,"given":"Dora A.","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose G.","family":"So\u00f1anez-Organis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy M.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mce.2022.111729_bib1","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41598-017-02570-x","article-title":"Angiotensin (1-7) ameliorates the structural and biochemical alterations of ovariectomy-induced osteoporosis in rats via activation of ACE-2\/Mas receptor axis","volume":"7","author":"Abuohashish","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.mce.2022.111729_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4236\/pp.2016.79046","article-title":"Role of angiotensin-(1-7) on renal hypertrophy in streptozotocin-induced diabetes mellitus","volume":"7","author":"Amato","year":"2016","journal-title":"Pharmacol. Pharm."},{"issue":"5","key":"10.1016\/j.mce.2022.111729_bib3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/hep.27695","article-title":"Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids","volume":"61","author":"Arendt","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mce.2022.111729_bib4","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1038\/s41467-020-16991-2","article-title":"Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation","volume":"11","author":"Barbier-Torres","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.mce.2022.111729_bib5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.mce.2022.111729_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.14348\/molcells.2021.2147","article-title":"Increased hepatic lipogenesis elevates liver cholesterol content","volume":"44","author":"Berger","year":"2021","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.mce.2022.111729_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.peptides.2012.08.002","article-title":"Decreased hepatic gluconeogenesis in transgenic rats with increased circulating angiotensin-(1-7)","volume":"37","author":"Bilman","year":"2012","journal-title":"Peptides"},{"issue":"8","key":"10.1016\/j.mce.2022.111729_bib8","doi-asserted-by":"crossref","first-page":"e0183278","DOI":"10.1371\/journal.pone.0183278","article-title":"Validation of commercial Mas receptor antibodies for utilization in Western Blotting, immunofluorescence and immunohistochemistry studies","volume":"12","author":"Burghi","year":"2017","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.mce.2022.111729_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2014.05.024","article-title":"The ACE2\/Ang-(1-7)\/Mas axis can inhibit hepatic insulin resistance","volume":"393","author":"Cao","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2022.111729_bib10","article-title":"Angiotensin-converting enzyme 2\/angiotensin-(1-7)\/Mas axis activates Akt signaling to ameliorate hepatic steatosis","volume":"6","author":"Cao","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.mce.2022.111729_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2007-979899","article-title":"Liver glucokinase: decreased activity in patients with type II diabetes","volume":"27","author":"Caro","year":"1995","journal-title":"Horm. Metab. Res."},{"issue":"4","key":"10.1016\/j.mce.2022.111729_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1158\/2159-8290.CD-12-0018","article-title":"Negative feedback and adaptive resistance to the targeted therapy of cancer","volume":"2","author":"Chandarlapaty","year":"2012","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.mce.2022.111729_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.12701\/yujm.2019.00059","article-title":"Telmisartan increases hepatic glucose production via protein kinase C zeta-dependent insulin receptor substrate-1 phosphorylation in HepG2 cells and mouse liver","volume":"36","author":"Cho","year":"2019","journal-title":"Yeungnam Univ. J. Med."},{"issue":"5","key":"10.1016\/j.mce.2022.111729_bib14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.physbeh.2010.03.018","article-title":"The renin angiotensin system and the metabolic syndrome","volume":"100","author":"de Kloet","year":"2010","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.mce.2022.111729_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10010194","article-title":"Detailed molecular mechanisms involved in drug-induced non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: an update","volume":"10","author":"Di Pasqua","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.mce.2022.111729_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.peptides.2012.03.022","article-title":"The cardiac expression of Mas receptor is responsive to different physiological and pathological stimuli","volume":"35","author":"Dias-Peixoto","year":"2012","journal-title":"Peptides"},{"issue":"19","key":"10.1016\/j.mce.2022.111729_bib17","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1161\/01.CIR.0000016049.86468.23","article-title":"Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma","volume":"105","author":"Diep","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mce.2022.111729_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2022.111729_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.peptides.2013.10.022","article-title":"Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo","volume":"51","author":"Echeverria-Rodriguez","year":"2014","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.mce.2022.111729_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.15171\/mejdd.2016.18","article-title":"The prevalence of metabolic syndrome in non-alcoholic fatty liver disease; A population-based study","volume":"8","author":"Fattahi","year":"2016","journal-title":"Middle East J. Dig. Dis."},{"issue":"1","key":"10.1016\/j.mce.2022.111729_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.mce.2022.111729_bib23","doi-asserted-by":"crossref","first-page":"e036663","DOI":"10.1136\/bmjopen-2019-036663","article-title":"Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: a population-based observational study","volume":"10","author":"Ge","year":"2020","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.mce.2022.111729_bib24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.5812\/ijem.3505","article-title":"Normality tests for statistical analysis: a guide for non-statisticians","volume":"10","author":"Ghasemi","year":"2012","journal-title":"Int. J. Endocrinol. Metabol."},{"key":"10.1016\/j.mce.2022.111729_bib25","article-title":"Chronic angiotensin receptor activation promotes hepatic triacylglycerol accumulation during an acute glucose challenge in obese-insulin-resistant OLETF rats","author":"Godoy-Lugo","year":"2021","journal-title":"Endocrine"},{"issue":"17","key":"10.1016\/j.mce.2022.111729_bib26","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American heart association\/national heart, lung, and blood institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.mce.2022.111729_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/147323000102900402","article-title":"Effect of the angiotensin II receptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertension","volume":"29","author":"Hanefeld","year":"2001","journal-title":"J. Int. Med. Res."},{"issue":"7","key":"10.1016\/j.mce.2022.111729_bib28","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI6246","article-title":"Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL","volume":"103","author":"Horton","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"18","key":"10.1016\/j.mce.2022.111729_bib29","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.mce.2022.111729_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1198\/sbr.2009.0025","article-title":"A theoretical framework for estimation of AUCs in complete and incomplete sampling designs","volume":"1","author":"Jaki","year":"2009","journal-title":"Stat. Biopharm. Res."},{"issue":"7","key":"10.1016\/j.mce.2022.111729_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","article-title":"Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets","volume":"11","author":"Jiang","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"6","key":"10.1016\/j.mce.2022.111729_bib32","doi-asserted-by":"crossref","first-page":"G1094","DOI":"10.1152\/ajpgi.00365.2010","article-title":"Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats","volume":"300","author":"Kaji","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.mce.2022.111729_bib33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.mce.2022.111729_bib34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fcell.2019.00248","article-title":"Fatty Liver Due to Increased de novo Lipogenesis: alterations in the Hepatic Peroxisomal Proteome","volume":"7","author":"Knebel","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.mce.2022.111729_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4097\/kjae.2017.70.4.407","article-title":"Statistical data preparation: management of missing values and outliers","volume":"70","author":"Kwak","year":"2017","journal-title":"Kor. J. Anesthesiol"},{"issue":"1","key":"10.1016\/j.mce.2022.111729_bib36","first-page":"21","article-title":"Effects of antihypertensive treatment with angiotensin II receptor blockers on lipid profile: an open multi-drug comparison trial","volume":"47","author":"Kyvelou","year":"2006","journal-title":"Hellenic J. Cardiol."},{"issue":"3","key":"10.1016\/j.mce.2022.111729_bib37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2022.111729_bib38","volume":"2019","author":"Li","year":"2019"},{"issue":"11","key":"10.1016\/j.mce.2022.111729_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/CS20080647","article-title":"Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat","volume":"117","author":"Lubel","year":"2009","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1\u20132","key":"10.1016\/j.mce.2022.111729_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mce.2012.04.013","article-title":"The role of angiotensin II in nonalcoholic steatohepatitis","volume":"378","author":"Matthew Morris","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.mce.2022.111729_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1470320310370852","article-title":"Review: angiotensin II type 1 receptor blockers: class effects versus molecular effects","volume":"12","author":"Miura","year":"2011","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"issue":"1","key":"10.1016\/j.mce.2022.111729_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.physbeh.2007.11.035","article-title":"Unraveling the obesity of OLETF rats","volume":"94","author":"Moran","year":"2008","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.mce.2022.111729_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.peptides.2017.04.004","article-title":"Long-term effects of angiotensin-(1-7) on lipid metabolism in the adipose tissue and liver","volume":"92","author":"Moreira","year":"2017","journal-title":"Peptides"},{"key":"10.1016\/j.mce.2022.111729_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinf."},{"issue":"3","key":"10.1016\/j.mce.2022.111729_bib47","first-page":"69","article-title":"Statistics corner: a guide to appropriate use of correlation coefficient in medical research","volume":"24","author":"Mukaka","year":"2012","journal-title":"Malawi Med. J."},{"issue":"6","key":"10.1016\/j.mce.2022.111729_bib48","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2337\/db08-0281","article-title":"Fatty acid oxidation and insulin action: when less is more","volume":"57","author":"Muoio","year":"2008","journal-title":"Diabetes"},{"issue":"Suppl. l","key":"10.1016\/j.mce.2022.111729_bib49","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1194\/jlr.R800053-JLR200","article-title":"Hepatic triacylglycerol accumulation and insulin resistance","volume":"50","author":"Nagle","year":"2009","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.mce.2022.111729_bib50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0003-2697(85)90234-9","article-title":"Microassay for proteins on nitrocellulose filter using protein dye-staining procedure","volume":"148","author":"Nakamura","year":"1985","journal-title":"Anal. Biochem."},{"issue":"5","key":"10.1016\/j.mce.2022.111729_bib51","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD single topic conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mce.2022.111729_bib52","first-page":"9","article-title":"Non alcoholic fatty liver disease and metabolic syndrome","volume":"13","author":"Paschos","year":"2009","journal-title":"Hippokratia"},{"issue":"8","key":"10.1016\/j.mce.2022.111729_bib53","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1-7 Axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.mce.2022.111729_bib54","article-title":"The role of lipid and lipoprotein metabolism in non-alcoholic fatty liver disease","volume":"4","author":"Perla","year":"2017","journal-title":"Children (Basel)"},{"issue":"7","key":"10.1016\/j.mce.2022.111729_bib55","doi-asserted-by":"crossref","first-page":"E1126","DOI":"10.1210\/jc.2010-2017","article-title":"Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans","volume":"96","author":"Peter","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.mce.2022.111729_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040702","article-title":"Update on new aspects of the renin-angiotensin system in hepatic fibrosis and portal hypertension: implications for novel therapeutic options","volume":"10","author":"Rajapaksha","year":"2021","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.mce.2022.111729_bib57","doi-asserted-by":"crossref","first-page":"E955","DOI":"10.1152\/ajpendo.00199.2004","article-title":"Chronic ANG II infusion increases plasma triglyceride level by stimulating hepatic triglyceride production in rats","volume":"287","author":"Ran","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.mce.2022.111729_bib58","doi-asserted-by":"crossref","first-page":"E227","DOI":"10.1152\/ajpendo.00090.2004","article-title":"Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats","volume":"287","author":"Ran","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.mce.2022.111729_bib59","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/01.hjh.0000174077.88121.19","article-title":"Angiotensin II infusion increases hepatic triglyceride production via its type 2 receptor in rats","volume":"23","author":"Ran","year":"2005","journal-title":"J. Hypertens."},{"issue":"5","key":"10.1016\/j.mce.2022.111729_bib60","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.HYP.0000209020.69734.73","article-title":"A place in our hearts for the lowly angiotensin 1-7 peptide?","volume":"47","author":"Reudelhuber","year":"2006","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.mce.2022.111729_bib61","doi-asserted-by":"crossref","first-page":"F1081","DOI":"10.1152\/ajprenal.00156.2018","article-title":"Angiotensin receptor and tumor necrosis factor-alpha activation contributes to glucose intolerance independent of systolic blood pressure in obese rats","volume":"315","author":"Rodriguez","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.mce.2022.111729_bib62","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1530\/JOE-17-0678","article-title":"Chronic AT1 blockade improves glucose homeostasis in obese OLETF rats","volume":"237","author":"Rodriguez","year":"2018","journal-title":"J. Endocrinol."},{"issue":"5","key":"10.1016\/j.mce.2022.111729_bib63","doi-asserted-by":"crossref","first-page":"E714","DOI":"10.1152\/ajpendo.00584.2020","article-title":"Chronic AT1 blockade improves hyperglycemia by decreasing adipocyte inflammation and decreasing hepatic PCK1 and G6PC1 expression in obese rats","volume":"321","author":"Rodriguez","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.mce.2022.111729_bib64","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1111\/j.1476-5381.2010.00835.x","article-title":"Irbesartan treatment up-regulates hepatic expression of PPARalpha and its target genes in obese Koletsky (fa(k)\/fa(k)) rats: a link to amelioration of hypertriglyceridaemia","volume":"160","author":"Rong","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.mce.2022.111729_bib66","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1210\/en.2016-1247","article-title":"The angiotensin-(1-7)\/mas Axis improves pancreatic beta-cell function in vitro and in vivo","volume":"157","author":"Sahr","year":"2016","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.mce.2022.111729_bib67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metabol."},{"issue":"5","key":"10.1016\/j.mce.2022.111729_bib68","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/ATVBAHA.109.200493","article-title":"Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7)","volume":"30","author":"Santos","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1\u20133","key":"10.1016\/j.mce.2022.111729_bib69","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.regpep.2012.06.009","article-title":"Increased circulating angiotensin-(1-7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet","volume":"178","author":"Santos","year":"2012","journal-title":"Regul. Pept."},{"key":"10.1016\/j.mce.2022.111729_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/342648","article-title":"Time course of the development of nonalcoholic Fatty liver disease in the Otsuka long-evans Tokushima Fatty rat","volume":"2013","author":"Song","year":"2013","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.mce.2022.111729_bib72","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.abb.2019.01.011","article-title":"Molecular and cellular regulation of human glucokinase","volume":"663","author":"Sternisha","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"issue":"8","key":"10.1016\/j.mce.2022.111729_bib73","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.7150\/ijbs.7.1077","article-title":"Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2\/angiotensin 1-7\/mas receptor axis","volume":"7","author":"Sukumaran","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.mce.2022.111729_bib74","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.redox.2017.10.005","article-title":"Angiotensin receptor blockade improves cardiac mitochondrial activity in response to an acute glucose load in obese insulin resistant rats","volume":"14","author":"Thorwald","year":"2018","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.mce.2022.111729_bib76","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/hep.22980","article-title":"Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids","volume":"50","author":"Villanueva","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mce.2022.111729_bib77","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jhep.2008.03.018","article-title":"Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats","volume":"49","author":"Wei","year":"2008","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.mce.2022.111729_bib78","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/en.2015-1866","article-title":"Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice","volume":"157","author":"Wilson","year":"2016","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.mce.2022.111729_bib79","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/157016111794519318","article-title":"Pleiotropic effects of ARB in metabolic syndrome","volume":"9","author":"Yamada","year":"2011","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"11","key":"10.1016\/j.mce.2022.111729_bib80","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1194\/jlr.R800018-JLR200","article-title":"Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis","volume":"49","author":"Yen","year":"2008","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.mce.2022.111729_bib81","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41387-018-0045-x","article-title":"Update on glycerol-3-phosphate acyltransferases: the roles in the development of insulin resistance","volume":"8","author":"Yu","year":"2018","journal-title":"Nutr. Diabetes"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720722001770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720722001770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:21:27Z","timestamp":1759587687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720722001770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":75,"alternative-id":["S0303720722001770"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2022.111729","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved lipogenesis gene expression in liver is associated with elevated plasma angiotensin 1-7 after AT1 receptor blockade in insulin-resistant OLETF rats","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2022.111729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111729"}}